ARHGAP1 and cancer: Extensive studies have shown that DLC1 utilizes this RhoGAP activity to suppress cell proliferation [15], [18], [23], [25]–[29], trigger apoptosis [25] and to reduce cell migration [26], [28], cell invasion and the resultant cancer metastasis in cell lines as well as mouse models with different tissue origins [29]–[31].